Report

protein expression market

Protein Expression Market By Expression Systems (Prokaryotic expression systems, Mammalian cell systems, Insect cell systems, Yeast systems, and Other systems), Product (Reagents, Competent cells, Expression vectors, Services, and Instruments), Application (Therapeutic, Industrial and Research), End-use (Pharmaceutical and biotechnological companies, Academic research, Contract research organizations, and Others) and Geography (North America, Europe, APAC and RoW) – Global Forecast to 2026

pages Pages: 118
tables Tables: 125
charts Charts: 88
country Regions/Countries: 4 / 10
compaines Companies: 17
enqhours Enquiry Hours: 10
  • Get Free 10% Customization in this Report

COVID - 19

Covid impact updated reports at special price

Protein expression is a process of producing proteins that are synthesized, modified, and regulated. Protein expression includes laboratory techniques & procedures which help in the production of proteins. The process enables to generate and purify the required protein, either within the cell or outside the cell. The technique of producing synthesized proteins, utilizing the protein expression process can be generally used for industrial purposes or to diagnose and treat diseases. The protein expression market growth can be attributed to key factors such as the rapidly increasing number of chronic diseases and the increase in funding availability for research on proteins. Huge costs incurred in protein expression reagents and instruments are restricting the protein expression market growth. The Protein Expression Market is expected to grow at a rate of 13.3% CAGR by 2026.

Research Methodology:

The pharmaceutical drug delivery market has been analyzed by utilizing the optimum combination of secondary sources and in-house methodology, along with an irreplaceable blend of primary insights. The real-time assessment of the market is an integral part of our market sizing and forecasting methodology. Our industry experts and panel of primary participants have helped in compiling relevant aspects with realistic parametric estimations for a comprehensive study. The participation share of different categories of primary participants is given below:

Protein Expression Market By Expression Systems

  • Prokaryotic expression systems
  • Mammalian cell systems
  • Insect cell systems
  • Yeast systems
  • Other systems

Protein Expression Market by Product

  • Reagents
  • Competent cells
  • Expression vectors
  • Services
  • Instruments

Protein Expression Market by Application

  • Therapeutic
  • Industrial
  • Research

Protein Expression Market by End-use

  • Pharmaceutical and biotechnological companies
  • Academic research
  • Contract research organizations
  • Others

Protein Expression Market by Geography

  • North America
  • Europe
  • Asia Pacific
  • Rest of the World

In the protein expression market, according to the expression system segment, the prokaryotic is the most commonly used expression in the protein expression process which is used for the protein synthesis, modification, and regulation of proteins in living organisms. The prokaryotic expression is widely used because of the high capability of the production of proteins and low-cost production.

As per the product segmentation in the protein expression market, the service segment is projected to have the highest CAGR rate. This is due to the increasing preference for the service for custom optimization and the availability of advanced products and research professionals.

The therapeutic application has a pivotal role in the protein expression market share based on the application. An enormous increase in the prevalence of chronic diseases and increasing research and development activity is fueling market growth. Furthermore, the key factor is the wide application of protein expression in the production of biologics.

The crucial end users of the protein expression market are the pharmaceutical and biotechnological companies and also have a major share in the market. This is because of the increasing requirement of the therapeutic proteins, which includes hormones, enzymes, anticoagulants, and the increasing expenditure in novel drug development.

Accordant to the regional market, North America is having the leading share in the protein expression market. This is because this region has the highest rate of deployment of the therapeutic based on biotechnology and the high contribution of pharmaceutical companies in designing protein-based medicines.

The crucial factors involved in the growth of the global protein expression market include the increase in the elderly population due to which there is a rising incidence of chronic diseases which is a major factor of the growth. Also, the increasing demand for protein biologics is another factor that is boosting the demand for the global market of protein expression.     

The significant market competitors of the protein expression market are Merck KGaA, GenScript Biotech Corporation, Agilent Technologies Inc., Bio-Rad Laboratories Inc., ProMab Biotechnologies Inc., Synthetic Genomics Inc., Lonza, Promega Corporation, Thermo Fisher Scientific Inc., Takara Bio, New England Biolabs, Oxford Expression Technologies Ltd., LifeSensors, ProteoGenix, Peak Proteins Ltd., Sino Biological Inc, and Lucigen Corporation.

Moreover, there are a number of research and developments that are continuously going on in the field of protein expression by various pharmaceutical and biopharmaceutical companies to bring advanced biologics.

  • This report provides insights into protein expression market trends and predictions of the future market size.
  • This report gives the major market dynamics and the factors affecting the protein expression market and its sub-segments.
  • This report also presents geographical dynamics of the protein expression market and insights into drivers and opportunities in the major regions such as North America, Europe, Asia-Pacific, and the Rest of the World.
  • This research presents the major shareholders, product portfolios, new developments, and the market players' competitive landscape.
  1. Executive Summary
  2. Industry Outlook
    1. Industry Overview
    2. Industry Trends
  3. Market Snapshot
    1. Market Definition
    2. Market Outlook
      1. PEST Analysis
      2. Porter Five Forces
    3. Related Markets
  4. Market characteristics
    1. Market Evolution
    2. Market Trends and Impact
    3. Advantages/Disadvantages of Market
    4. Regulatory Impact
    5. Market Offerings
    6. Market Segmentation
    7. Market Dynamics
      1. Drivers
      2. Restraints
      3. Opportunities
    8. DRO - Impact Analysis
  5. Products: Market Size & Analysis
    1. Overview
    2. Prokaryotic expression systems
    3. Mammalian cell systems
    4. Insect cell systems
    5. Yeast systems
    6. Other systems
  6.  Component: Market Size & Analysis
    1. Overview
    2. Reagents
    3. Competent cells
    4. Expression vectors
    5. Services
    6. Instruments
  7. Mode of Delivery: Market Size & Analysis
    1. Overview
    2. Therapeutic
    3. Industrial
    4. Research
  8. End User: Market Size & Analysis
    1. Overview
    2. Pharmaceutical and biotechnological companies
    3. Academic research
    4. Contract research organizations
    5. Others
  9. Geography: Market Size & Analysis
    1. Overview
    2. North America
    3. Europe
    4. Asia Pacific
    5. Rest of the World
  10. Competitive Landscape
    1. Competitor Comparison Analysis
    2. Market Developments
      1. Mergers and Acquisitions, Legal, Awards, Partnerships
      2. Product Launches and execution
  11. Vendor Profiles
    1. Merck KGaA
      1. Overview
      2. Financials
      3. Products / Services
      4. Recent Developments
      5. Business Strategy
      6.  
    2. GenScript Biotech Corporation
      1. Overview
      2. Financials
      3. Products / Services
      4. Recent Developments
      5. Business Strategy
    3. Agilent Technologies Inc
      1. Overview
      2. Financials
      3. Products / Services
      4. Recent Developments
      5. Business Strategy
    4. Bio-Rad Laboratories Inc
      1. Overview
      2. Financials
      3. Products / Services
      4. Recent Developments
      5. Business Strategy
    5. ProMab Biotechnologies Inc
      1. Overview
      2. Financials
      3. Products / Services
      4. Recent Developments
      5. Business Strategy
      6.  
    6. Synthetic Genomics Inc
      1. Overview
      2. Financials
      3. Products / Services
      4. Recent Developments
      5. Business Strategy
      6.  
    7. Lonza
      1. Overview
      2. Financials
      3. Products / Services
      4. Recent Developments
      5. Business Strategy
    8. Promega Corporation
      1. Overview
      2. Financials
      3. Products / Services
      4. Recent Developments
      5. Business Strategy
      6.  
    9. Thermo Fisher Scientific Inc
      1. Overview
      2. Financials
      3. Products / Services
      4. Recent Developments
      5. Business Strategy
      6.  
    10. Takara Bio
      1. Overview
      2. Financials
      3. Products / Services
      4. Recent Developments
      5. Business Strategy
  12. Companies to Watch
    1. New England Biolabs
      1. Overview
      2. Product / Services
      3. Business Strategy
    2. Oxford Expression Technologies Ltd
      1. Overview
      2. Product / Services
      3. Business Strategy
    3. LifeSensors
      1. Overview
      2. Product / Services
      3. Business Strategy
      4.  
    4. ProteoGenix
      1. Overview
      2. Product / Services
      3. Business Strategy
    5. Peak Proteins Ltd
      1. Overview
      2. Product / Services
      3. Business Strategy
    6. Sino Biological Inc
      1. Overview
      2. Product / Services
      3. Business Strategy
    7. Lucigen Corporation
      1. Overview
      2. Product / Services
      3. Business Strategy
      4. v
  13. Analyst Opinion
  14. Annexure
    1. Report Scope
    2. Market Definitions
    3. Research Methodology
      1. Data Collation and In-house Estimation
      2. Market Triangulation
      3. Forecasting
    4. Report Assumptions
    5. Declarations
    6. Stakeholders
    7. Abbreviations

TABLE 1.       GLOBAL PROTEIN EXPRESSION MARKET VALUE, BY EXPRESSION SYSTEMS, 2020-2026 (USD BILLION)

TABLE 2.       GLOBAL PROTEIN EXPRESSION MARKET VALUE FOR PROKARYOTIC EXPRESSION SYSTEMS, BY GEOGRAPHY, 2020-2026 (USD BILLION)

TABLE 3.       GLOBAL PROTEIN EXPRESSION MARKET VALUE FOR MAMMALIAN CELL SYSTEMS, BY GEOGRAPHY, 2020-2026 (USD BILLION)

TABLE 4.       GLOBAL PROTEIN EXPRESSION MARKET VALUE FOR INSECT CELL SYSTEMS, BY GEOGRAPHY, 2020-2026 (USD BILLION)

TABLE 5.       GLOBAL PROTEIN EXPRESSION MARKET VALUE FOR YEAST SYSTEMS, BY GEOGRAPHY, 2020-2026 (USD BILLION)

TABLE 6.       GLOBAL PROTEIN EXPRESSION MARKET VALUE FOR OTHER SYSTEMS, BY GEOGRAPHY, 2020-2026 (USD BILLION)

TABLE 7.       GLOBAL PROTEIN EXPRESSION MARKET VALUE, BY PRODUCT, 2020-2026 (USD BILLION)

TABLE 8.       GLOBAL PROTEIN EXPRESSION MARKET VALUE FOR REAGENTS, BY GEOGRAPHY, 2020-2026 (USD BILLION)

TABLE 9.       GLOBAL PROTEIN EXPRESSION MARKET VALUE FOR COMPETENT CELLS, BY GEOGRAPHY, 2020-2026 (USD BILLION)

TABLE 10.      GLOBAL PROTEIN EXPRESSION MARKET VALUE FOR EXPRESSION VECTORS, BY GEOGRAPHY, 2020-2026 (USD BILLION)

TABLE 11.      GLOBAL PROTEIN EXPRESSION MARKET VALUE FOR SERVICES, BY GEOGRAPHY, 2020-2026 (USD BILLION)

TABLE 12.      GLOBAL PROTEIN EXPRESSION MARKET VALUE FOR INSTRUMENTS, BY GEOGRAPHY, 2020-2026 (USD BILLION)

TABLE 13.      GLOBAL PROTEIN EXPRESSION MARKET VALUE FOR APPLICATION, BY GEOGRAPHY, 2020-2026 (USD BILLION)

TABLE 14.      GLOBAL PROTEIN EXPRESSION MARKET VALUE FOR THERAPEUTIC, BY GEOGRAPHY, 2020-2026 (USD BILLION)

TABLE 15.      GLOBAL PROTEIN EXPRESSION MARKET VALUE FOR INDUSTRIAL, BY GEOGRAPHY, 2020-2026 (USD BILLION)

TABLE 16.      GLOBAL PROTEIN EXPRESSION MARKET VALUE FOR RESEARCH, BY GEOGRAPHY, 2020-2026 (USD BILLION)

TABLE 17.      GLOBAL PROTEIN EXPRESSION MARKET VALUE, BY END-USER, 2020-2026 (USD BILLION)

TABLE 18.      GLOBAL PROTEIN EXPRESSION MARKET VALUE FOR PHARMACEUTICAL AND BIOTECHNOLOGICAL COMPANIES, 2020-2026 (USD BILLION)

TABLE 19.      GLOBAL PROTEIN EXPRESSION MARKET VALUE FOR ACADEMIC RESEARCH, BY GEOGRAPHY, 2020-2026 (USD BILLION)

TABLE 20.      GLOBAL PROTEIN EXPRESSION MARKET VALUE FOR CONTRACT RESEARCH ORGANIZATIONS, BY GEOGRAPHY, 2020-2026 (USD BILLION)

TABLE 21.      GLOBAL PROTEIN EXPRESSION MARKET VALUE FOR OTHERS, BY GEOGRAPHY, 2020-2026 (USD BILLION)

TABLE 22.      NORTH AMERICA PROTEIN EXPRESSION MARKET VALUE, BY COUNTRY, 2020-2026 (USD BILLION)

TABLE 23.      NORTH AMERICA PROTEIN EXPRESSION MARKET VALUE, BY EXPRESSION SYSTEMS, 2020-2026 (USD BILLION)

TABLE 24.      NORTH AMERICA PROTEIN EXPRESSION MARKET VALUE, BY PRODUCT, 2020-2026 (USD BILLION)

TABLE 25.      NORTH AMERICA PROTEIN EXPRESSION MARKET VALUE, BY APPLICATION, 2020-2026 (USD BILLION)

TABLE 26.      NORTH AMERICA PROTEIN EXPRESSION MARKET VALUE, BY END-USER, 2020-2026 (USD BILLION)

TABLE 27.      U.S PROTEIN EXPRESSION MARKET VALUE, BY EXPRESSION SYSTEMS, 2020-2026 (USD BILLION)

TABLE 28.      U.S PROTEIN EXPRESSION MARKET VALUE, BY PRODUCT, 2020-2026 (USD BILLION)

TABLE 29.      U.S PROTEIN EXPRESSION MARKET VALUE, BY APPLICATION, 2020-2026 (USD BILLION)

TABLE 30.      U.S PROTEIN EXPRESSION MARKET VALUE, BY END-USER, 2020-2026 (USD BILLION)

TABLE 31.      CANADA PROTEIN EXPRESSION MARKET VALUE, BY EXPRESSION SYSTEMS, 2020-2026 (USD BILLION)

TABLE 32.      CANADA PROTEIN EXPRESSION MARKET VALUE, BY PRODUCT, 2020-2026 (USD BILLION)

TABLE 33.      CANADA PROTEIN EXPRESSION MARKET VALUE, BY APPLICATION, 2020-2026 (USD BILLION)

TABLE 34.      CANADA PROTEIN EXPRESSION MARKET VALUE, BY END-USER, 2020-2026 (USD BILLION)

TABLE 35.      EUROPE PROTEIN EXPRESSION MARKET VALUE, BY COUNTRY, 2020-2026 (USD BILLION)

TABLE 36.      EUROPE PROTEIN EXPRESSION MARKET VALUE, BY EXPRESSION SYSTEMS, 2020-2026 (USD BILLION)

TABLE 37.      EUROPE PROTEIN EXPRESSION MARKET VALUE, BY PRODUCT, 2020-2026 (USD BILLION)

TABLE 38.      EUROPE PROTEIN EXPRESSION MARKET VALUE, APPLICATION, 2020-2026 (USD BILLION)

TABLE 39.      EUROPE PROTEIN EXPRESSION MARKET VALUE, END-USER, 2020-2026 (USD BILLION)

TABLE 40.      GERMANY PROTEIN EXPRESSION MARKET VALUE, BY EXPRESSION SYSTEMS, 2020-2026 (USD BILLION)

TABLE 41.      GERMANY PROTEIN EXPRESSION MARKET VALUE, BY PRODUCT, 2020-2026 (USD BILLION)

TABLE 42.      GERMANY PROTEIN EXPRESSION MARKET VALUE, BY APPLICATION, 2020-2026 (USD BILLION)

TABLE 43.      GERMANY PROTEIN EXPRESSION MARKET VALUE, BY END-USER, 2020-2026 (USD BILLION)

TABLE 44.      U.K PROTEIN EXPRESSION MARKET VALUE, BY EXPRESSION SYSTEMS, 2020-2026 (USD BILLION)

TABLE 45.      U.K PROTEIN EXPRESSION MARKET VALUE, BY PRODUCT, 2020-2026 (USD BILLION)

TABLE 46.      U.K PROTEIN EXPRESSION MARKET VALUE, BY APPLICATION, 2020-2026 (USD BILLION)

TABLE 47.      U.K PROTEIN EXPRESSION MARKET VALUE, BY END-USER, 2020-2026 (USD BILLION)

TABLE 48.      FRANCE PROTEIN EXPRESSION MARKET VALUE, BY EXPRESSION SYSTEMS, 2020-2026 (USD BILLION)

TABLE 49.      FRANCE PROTEIN EXPRESSION MARKET VALUE, BY PRODUCT, 2020-2026 (USD BILLION)

TABLE 50.      FRANCE PROTEIN EXPRESSION MARKET VALUE, BY END-USER, 2020-2026 (USD BILLION)

TABLE 51.      FRANCE PROTEIN EXPRESSION MARKET VALUE, BY APPLICATION, 2020-2026 (USD BILLION)

TABLE 52.      ITALY PROTEIN EXPRESSION MARKET VALUE, BY EXPRESSION SYSTEMS, 2020-2026 (USD BILLION)

TABLE 53.      ITALY PROTEIN EXPRESSION MARKET VALUE, BY PRODUCT, 2020-2026 (USD BILLION)

TABLE 54.      ITALY PROTEIN EXPRESSION MARKET VALUE, BY APPLICATION, 2020-2026 (USD BILLION)

TABLE 55.      ITALY PROTEIN EXPRESSION MARKET VALUE, BY END-USER, 2020-2026 (USD BILLION)

TABLE 56.      SPAIN PROTEIN EXPRESSION MARKET VALUE, BY EXPRESSION SYSTEMS, 2020-2026 (USD BILLION)

TABLE 57.      SPAIN PROTEIN EXPRESSION MARKET VALUE, BY PRODUCT, 2020-2026 (USD BILLION)

TABLE 58.      SPAIN PROTEIN EXPRESSION MARKET VALUE, BY APPLICATION, 2020-2026 (USD BILLION)

TABLE 59.      SPAIN PROTEIN EXPRESSION MARKET VALUE, BY END-USER, 2020-2026 (USD BILLION)

TABLE 60.      ROE PROTEIN EXPRESSION MARKET VALUE, BY EXPRESSION SYSTEMS, 2020-2026 (USD BILLION)

TABLE 61.      ROE PROTEIN EXPRESSION MARKET VALUE, BY PRODUCT, 2020-2026 (USD BILLION)

TABLE 62.      ROE PROTEIN EXPRESSION MARKET VALUE, BY APPLICATION, 2020-2026 (USD BILLION)

TABLE 63.      ROE PROTEIN EXPRESSION MARKET VALUE, BY END-USER, 2020-2026 (USD BILLION)

TABLE 64.      ASIA PACIFIC PROTEIN EXPRESSION MARKET VALUE, BY COUNTRY, 2020-2026 (USD BILLION)

TABLE 65.      ASIA PACIFIC PROTEIN EXPRESSION MARKET VALUE, BY EXPRESSION SYSTEMS, 2020-2026 (USD BILLION)

TABLE 66.      ASIA PACIFIC PROTEIN EXPRESSION MARKET VALUE, BY PRODUCT, 2020-2026 (USD BILLION)

TABLE 67.      ASIA PACIFIC PROTEIN EXPRESSION MARKET VALUE, BY APPLICATION, 2020-2026 (USD BILLION)

TABLE 68.      ASIA PACIFIC PROTEIN EXPRESSION MARKET VALUE, BY END-USER, 2020-2026 (USD BILLION)

TABLE 69.      CHINA PROTEIN EXPRESSION MARKET VALUE, BY EXPRESSION SYSTEMS, 2020-2026 (USD BILLION)

TABLE 70.      CHINA PROTEIN EXPRESSION MARKET VALUE, BY PRODUCT, 2020-2026 (USD BILLION)

TABLE 71.      CHINA PROTEIN EXPRESSION MARKET VALUE, BY APPLICATION, 2020-2026 (USD BILLION)

TABLE 72.      CHINA PROTEIN EXPRESSION MARKET VALUE, BY END-USER, 2020-2026 (USD BILLION)

TABLE 73.      INDIA PROTEIN EXPRESSION MARKET VALUE, BY EXPRESSION SYSTEMS, 2020-2026 (USD BILLION)

TABLE 74.      INDIA PROTEIN EXPRESSION MARKET VALUE, BY PRODUCT, 2020-2026 (USD BILLION)

TABLE 75.      INDIA PROTEIN EXPRESSION MARKET VALUE, BY APPLICATION, 2020-2026 (USD BILLION)

TABLE 76.      INDIA PROTEIN EXPRESSION MARKET VALUE, BY END-USER, 2020-2026 (USD BILLION)

TABLE 77.      JAPAN PROTEIN EXPRESSION MARKET VALUE, BY EXPRESSION SYSTEMS, 2020-2026 (USD BILLION)

TABLE 78.      JAPAN PROTEIN EXPRESSION MARKET VALUE, BY PRODUCT, 2020-2026 (USD BILLION)

TABLE 79.      JAPAN PROTEIN EXPRESSION MARKET VALUE, BY APPLICATION, 2020-2026 (USD BILLION)

TABLE 80.      JAPAN PROTEIN EXPRESSION MARKET VALUE, BY END-USER, 2020-2026 (USD BILLION)

TABLE 81.      REST OF APAC PROTEIN EXPRESSION MARKET VALUE, BY EXPRESSION SYSTEMS, 2020-2026 (USD BILLION)

TABLE 82.      REST OF APAC PROTEIN EXPRESSION MARKET VALUE, BY PRODUCT, 2020-2026 (USD BILLION)

TABLE 83.      REST OF APAC PROTEIN EXPRESSION MARKET VALUE, BY APPLICATION, 2020-2026 (USD BILLION)

TABLE 84.      REST OF APAC PROTEIN EXPRESSION MARKET VALUE, BY END-USER, 2020-2026 (USD BILLION)

TABLE 85.      REST OF WORLD PROTEIN EXPRESSION MARKET VALUE, BY EXPRESSION SYSTEMS, 2020-2026 (USD BILLION)

TABLE 86.      REST OF WORLD PROTEIN EXPRESSION MARKET VALUE, BY PRODUCT, 2020-2026 (USD BILLION)

TABLE 87.      REST OF WORLD PROTEIN EXPRESSION MARKET VALUE, BY APPLICATION, 2020-2026 (USD BILLION)

TABLE 88.      REST OF WORLD PROTEIN EXPRESSION MARKET VALUE, BY END-USER, 2020-2026 (USD BILLION)

TABLE 89.      MERCK KGAA: FINANCIALS 

TABLE 90.      MERCK KGAA: PRODUCTS & SERVICES     

TABLE 91.      MERCK KGAA: RECENT DEVELOPMENTS    

TABLE 92.      GENSCRIPT BIOTECH CORPORATION: FINANCIALS        

TABLE 93.      GENSCRIPT BIOTECH CORPORATION: PRODUCTS & SERVICES  

TABLE 94.      GENSCRIPT BIOTECH CORPORATION: RECENT DEVELOPMENTS 

TABLE 95.      AGILENT TECHNOLOGIES INC: FINANCIALS        

TABLE 96.      AGILENT TECHNOLOGIES INC: PRODUCTS & SERVICES  

TABLE 97.      AGILENT TECHNOLOGIES INC: RECENT DEVELOPMENTS 

TABLE 98.      BIO-RAD LABORATORIES INC: FINANCIALS        

TABLE 99.      BIO-RAD LABORATORIES INC: PRODUCTS & SERVICES  

TABLE 100.    BIO-RAD LABORATORIES INC: RECENT DEVELOPMENTS 

TABLE 101.    PROMAB BIOTECHNOLOGIES INC: FINANCIALS   

TABLE 102.    PROMAB BIOTECHNOLOGIES INC: PRODUCTS & SERVICES      

TABLE 103.    PROMAB BIOTECHNOLOGIES INC: RECENT DEVELOPMENTS     

TABLE 104.    SYNTHETIC GENOMICS INC: FINANCIALS 

TABLE 105.    SYNTHETIC GENOMICS INC: PRODUCTS & SERVICES     

TABLE 106.    SYNTHETIC GENOMICS INC: RECENT DEVELOPMENTS    

TABLE 107.    LONZA: FINANCIALS

TABLE 108.    LONZA: PRODUCTS & SERVICES    

TABLE 109.    LONZA: RECENT DEVELOPMENTS   

TABLE 110.    PROMEGA CORPORATION: FINANCIALS    

TABLE 111.    PROMEGA CORPORATION: PRODUCTS & SERVICES       

TABLE 112.    PROMEGA CORPORATION: RECENT DEVELOPMENTS      

TABLE 113.    THERMO FISHER SCIENTIFIC INC: FINANCIALS   

TABLE 114.    THERMO FISHER SCIENTIFIC INC: PRODUCTS & SERVICES      

TABLE 115.    THERMO FISHER SCIENTIFIC INC: RECENT DEVELOPMENTS     

TABLE 116.    TAKARA BIO: FINANCIALS  

TABLE 117.    TAKARA BIO: PRODUCTS & SERVICES      

TABLE 118.    TAKARA BIO: RECENT DEVELOPMENTS     

TABLE 119.    NEW ENGLAND BIOLABS: PRODUCTS & SERVICES        

TABLE 120.    OXFORD EXPRESSION TECHNOLOGIES LTD: PRODUCTS & SERVICES  

TABLE 121.    LIFESENSORS: PRODUCTS & SERVICES    

TABLE 122.    PROTEOGENIX: PRODUCTS & SERVICES   

TABLE 123.    PEAK PROTEINS LTD: PRODUCTS & SERVICES    

TABLE 124.    SINO BIOLOGICAL INC: PRODUCTS & SERVICES 

TABLE 125.    LUCIGEN CORPORATION: PRODUCTS & SERVICES         

Research Framework

Infoholic Research works on a holistic 360° approach in order to deliver high quality, validated and reliable information in our market reports. The Market estimation and forecasting involves following steps:

  • Data Collation (Primary & Secondary)
  • In-house Estimation (Based on proprietary data bases and Models)
  • Market Triangulation
  • Forecasting
Methodology

Market related information is congregated from both primary and secondary sources.

Primary sources

Involved participants from all global stakeholders such as Solution providers, service providers, Industry associations, thought leaders etc. across levels such as CXOs, VPs and managers. Plus, our in-house industry experts having decades of industry experience contribute their consulting and advisory services.

Secondary sources

Include public sources such as regulatory frameworks, government IT spending, government demographic indicators, industry association statistics, and company publications along with paid sources such as Factiva, OneSource, Bloomberg among others.

outicon

Protein Expression Market By Expression Systems (Prokaryotic expression systems, Mammalian cell systems, Insect cell systems, Yeast systems, and Other systems), Product (Reagents, Competent cells, Expression vectors, Services, and Instruments), Application (Therapeutic, Industrial and Research), End-use (Pharmaceutical and biotechnological companies, Academic research, Contract research organizations, and Others) and Geography (North America, Europe, APAC and RoW) – Global Forecast to 2026
Interested in this report?
Get your FREE sample now!

Select User License

$

Want to customize this report?

This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time.

We offer 10% worth of FREE customization at the time of purchase

Speak to our analyst
Related Reports